Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-02-2013 | Article

Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus

Authors: M. García-Álvarez, J. Berenguer, E. Álvarez, M. Guzmán-Fulgencio, J. Cosín, P. Miralles, P. Catalán, J. C. López, J. Ma Rodríguez, D. Micheloud, Ma Á. Muñoz-Fernández, S. Resino

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2013

Abstract

Torque teno virus (TTV) and torque teno mini virus (TTMV) have been potentially related to liver diseases. The aim of the study was to quantify TTV and TTMV in human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected patients to study the relationship between the TTV and TTMV viral loads and the severity of liver disease. We carried out a cross-sectional study in 245 patients coinfected with HIV and HCV (HIV/HCV-group), 114 patients monoinfected with HIV (HIV-group), and 100 healthy blood donors (Control-group). Plasma samples were tested for TTV and TTMV by quantitative real-time polymerase chain reaction (PCR). The prevalences of TTV and TTMV infections in the HIV/HCV-group and the HIV-group were significantly higher than the Control-group (p < 0.05). Furthermore, TTV and TTMV coinfections were found in 92.2 % (226/245) in the HIV/HCV-group, 84.2 % (96/114) in the HIV-group, and 63 % (63/100 %) in the Control-group (p ≤ 0.05). HIV/HCV-coinfected patients with HIV viral load ≥50 copies/mL and patients with severe activity grade had the highest viral loads of TTV and TTMV (p ≤ 0.05). HIV/HCV-coinfected patients with high TTV load (>2.78 log copies/μL) had increased odds of having advanced fibrosis or severe necroinflammatory activity grade in the liver biopsy. Moreover, HIV/HCV-coinfected patients with high TTMV load (>1.88 log copies/μL) had decreased odds of having no/minimal fibrosis and no/mild activity grade, and increased odds of having a high fibrosis progression rate. In conclusion, TTV and TTMV might play a role in the development of liver disease in immunodeficiency patients, such as the patients coinfected with HIV and HCV.

Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M (1997) A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 241(1):92–97PubMedCrossRef

Takahashi K, Iwasa Y, Hijikata M, Mishiro S (2000) Identification of a new human DNA virus (TTV-like mini virus, TLMV) intermediately related to TT virus and chicken anemia virus. Arch Virol 145(5):979–993PubMedCrossRef

Huang LY, Øystein Jonassen T, Hungnes O, Grinde B (2001) High prevalence of TT virus-related DNA (90%) and diverse viral genotypes in Norwegian blood donors. J Med Virol 64(3):381–386PubMedCrossRef

Takahashi K, Hoshino H, Ohta Y, Yoshida N, Mishiro S (1998) Very high prevalence of TT virus (TTV) infection in general population of Japan revealed by a new set of PCR primers. Hepatol Res 12:233–239CrossRef

Okamoto H (2009) History of discoveries and pathogenicity of TT viruses. Curr Top Microbiol Immunol 331:1–20PubMedCrossRef

Davidson F, MacDonald D, Mokili JLK, Prescott LE, Graham S, Simmonds P (1999) Early acquisition of TT virus (TTV) in an area endemic for TTV infection. J Infect Dis 179(5):1070–1076PubMedCrossRef

Ball JK, Curran R, Berridge S, Grabowska AM, Jameson CL, Thomson BJ, Irving WL, Sharp PM (1999) TT virus sequence heterogeneity in vivo: evidence for co-infection with multiple genetic types. J Gen Virol 80(Pt 7):1759–1768PubMed

Sugiyama K, Goto K, Ando T, Mizutani F, Terabe K, Kawabe Y, Wada Y (1999) Route of TT virus infection in children. J Med Virol 59(2):204–207PubMedCrossRef

Simmonds P, Davidson F, Lycett C, Prescott LE, MacDonald DM, Ellender J, Yap PL, Ludlam CA, Haydon GH, Gillon J, Jarvis LM (1998) Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet 352(9123):191–195PubMedCrossRef

10.

Shibayama T, Masuda G, Ajisawa A, Takahashi M, Nishizawa T, Tsuda F, Okamoto H (2001) Inverse relationship between the titre of TT virus DNA and the CD4 cell count in patients infected with HIV. AIDS 15(5):563–570PubMedCrossRef

11.

Christensen JK, Eugen-Olsen J, Sorensen M, Ullum H, Gjedde SB, Pedersen BK, Nielsen JO, Krogsgaard K (2000) Prevalence and prognostic significance of infection with TT virus in patients infected with human immunodeficiency virus. J Infect Dis 181(5):1796–1799PubMedCrossRef

12.

Okamoto H, Nishizawa T, Ukita M (1999) A novel unenveloped DNA virus (TT virus) associated with acute and chronic non-A to G hepatitis. Intervirology 42(2–3):196–204PubMedCrossRef

13.

Focosi D, Maggi F, Albani M, Macera L, Ricci V, Gragnani S, Di Beo S, Ghimenti M, Antonelli G, Bendinelli M, Pistello M, Ceccherini-Nelli L, Petrini M (2010) Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitution. J Clin Virol 47(2):189–192PubMedCrossRef

14.

Kaufmann GR, Elzi L, Weber R, Furrer H, Giulieri S, Vernazza P, Bernasconi E, Hirschel B, Battegay M; Swiss HIV Cohort Study (2011) Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death. AIDS 25(4):441–451PubMedCrossRef

15.

Madsen CD, Eugen-Olsen J, Kirk O, Parner J, Kaae Christensen J, Brasholt MS, Ole Nielsen J, Krogsgaard K (2002) TTV viral load as a marker for immune reconstitution after initiation of HAART in HIV-infected patients. HIV Clin Trials 3(4):287–295PubMedCrossRef

16.

Okamoto H, Ukita M, Nishizawa T, Kishimoto J, Hoshi Y, Mizuo H, Tanaka T, Miyakawa Y, Mayumi M (2000) Circular double-stranded forms of TT virus DNA in the liver. J Virol 74(11):5161–5167PubMedCrossRef

17.

Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Iizuka H, Miyakawa Y, Mayumi M (1998) Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 10(1):1–16CrossRef

18.

Kao JH, Chen W, Chen PJ, Lai MY, Chen DS (2000) TT virus infection in patients with chronic hepatitis B or C: Influence on clinical, histological and virological features. J Med Virol 60(4):387–392PubMedCrossRef

19.

Charlton M, Adjei P, Poterucha J, Zein N, Moore B, Therneau T, Krom R, Wiesner R (1998) TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology 28(3):839–842PubMedCrossRef

20.

Ikeda H, Takasu M, Inoue K, Okamoto H, Miyakawa Y, Mayumi M (1999) Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for hepatitis C virus RNA. J Hepatol 30(2):205–212PubMedCrossRef

21.

Tokita H, Murai S, Kamitsukasa H, Yagura M, Harada H, Takahashi M, Okamoto H (2002) High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease. J Med Virol 67(4):501–509PubMedCrossRef

22.

Zein NN, Arslan M, Li H, Charlton MR, Gross JB Jr, Poterucha JJ, Therneau TM, Kolbert CP, Persing DH (1999) Clinical significance of TT virus infection in patients with chronic hepatitis C. Am J Gastroenterol 94(10):3020–3027PubMedCrossRef

23.

Moriyama M, Matsumura H, Shimizu T, Shioda A, Kaneko M, Miyazawa K, Miyata H, Tanaka N, Uchida T, Arakawa Y (2001) Histopathologic impact of TT virus infection on the liver of type C chronic hepatitis and liver cirrhosis in Japan. J Med Virol 64(1):74–81PubMedCrossRef

24.

Alvarez do Barrio M, González Díez R, Hernández Sánchez JM, Oyonarte Gómez S (2005) Residual risk of transfusion-transmitted viral infections in Spain, 1997–2002, and impact of nucleic acid testing. Euro Surveill 10(2):20–22PubMed

25.

Jacobs WH, Goldberg SB, Balint JA, Boyce HW, Browning TH, Cooper JN, Earnest DL, Friedman E, Greene M, Mellow MA, Pitt HA, Todaro JL; Patient Care Committee of the American Gastroenterological Association (1989) Statement on outpatient percutaneous liver biopsy. Dig Dis Sci 34(3):322–323PubMedCrossRef

26.

Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24(2):289–293PubMedCrossRef

27.

Moen EM, Sleboda J, Grinde B (2002) Real-time PCR methods for independent quantitation of TTV and TLMV. J Virol Methods 104(1):59–67PubMedCrossRef

28.

Biagini P, Gallian P, Touinssi M, Cantaloube JF, Zapitelli JP, de Lamballerie X, de Micco P (2000) High prevalence of TT virus infection in French blood donors revealed by the use of three PCR systems. Transfusion 40(5):590–595PubMedCrossRef

29.

Maggi F, Bendinelli M (2009) Immunobiology of the Torque teno viruses and other anelloviruses. Curr Top Microbiol Immunol 331:65–90PubMedCrossRef

30.

Griffiths P (1999) Time to consider the concept of a commensal virus? Rev Med Virol 9(2):73–74PubMedCrossRef

31.

Zhong S, Yeo W, Tang MW, Lin XR, Mo F, Ho WM, Hui P, Johnson PJ (2001) Gross elevation of TT Virus genome load in the peripheral blood mononuclear Cells of cancer patients. Ann N Y Acad Sci 945:84–92PubMedCrossRef

32.

Touinssi M, Gallian P, Biagini P, Attoui H, Vialettes B, Berland Y, Tamalet C, Dhiver C, Ravaux I, De Micco P, De Lamballerie X (2001) TT virus infection: prevalence of elevated viraemia and arguments for the immune control of viral load. J Clin Virol 21(2):135–141PubMedCrossRef

33.

Thom K, Petrik J (2007) Progression towards AIDS leads to increased torque teno virus and torque teno minivirus titers in tissues of HIV infected individuals. J Med Virol 79(1):1–7PubMedCrossRef

34.

Mariscal LF, López-Alcorocho JM, Rodríguez-Iñigo E, Ortiz-Movilla N, de Lucas S, Bartolomé J, Carreño V (2002) TT virus replicates in stimulated but not in nonstimulated peripheral blood mononuclear cells. Virology 301(1):121–129PubMedCrossRef

35.

Reiberger T, Ferlitsch A, Sieghart W, Kreil A, Breitenecker F, Rieger A, Schmied B, Gangl A, Peck-Radosavljevic M (2010) HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension. J Viral Hepat 17(6):400–409PubMedCrossRef

36.

Thorpe J, Saeed S, Moodie EE, Klein MB; Canadian Co-infection Cohort Study (CTN222) (2011) Antiretroviral treatment interruption leads to progression of liver fibrosis in HIV-hepatitis C virus co-infection. AIDS 25(7):967–975PubMedCrossRef

37.

Shang D, Lin YH, Rigopoulou I, Chen B, Alexander GJM, Allain JP (2000) Detection of TT virus DNA in patients with liver disease and recipients of liver transplant. J Med Virol 61(4):455–461PubMedCrossRef

38.

Bendinelli M, Pistello M, Maggi F, Fornai C, Freer G, Vatteroni ML (2001) Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans. Clin Microbiol Rev 14(1):98–113PubMedCrossRef

39.

40.

Sioda A, Moriyama M, Matsumura H, Kaneko M, Tanaka N, Arakawa Y (2001) Clinicopathological features of serum TTV DNA-positive non-A-G liver diseases in Japan. Hepatol Res 21(2):169–180PubMedCrossRef

41.

Masia G, Ingianni A, Demelia L, Faa G, Manconi PE, Pilleri G, Ciancio A, Rizzetto M, Coppola RC (2001) TT virus infection in Italy: prevalence and genotypes in healthy subjects, viral liver diseases and asymptomatic infections by parenterally transmitted viruses. J Viral Hepat 8(5):384–390PubMedCrossRef

42.

Shieh B, Chang MJ, Ko WC, Chen EJ, Wu JC, Lee CF, Chang TT, Li C (2003) Effects of multiple virus coinfections on disease progression in HIV-positive patients. Intervirology 46(2):105–113PubMedCrossRef

43.

Hofer H, Aydin I, Neumueller-Guber S, Mueller C, Scherzer TM, Staufer K, Steindl-Munda P, Wrba F, Ferenci P (2011) Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy. J Viral Hepat 18(7):513–517PubMedCrossRef

44.

Moriyama M, Matsumura H, Shimizu T, Shioda A, Kaneko M, Saito H, Miyazawa K, Tanaka N, Sugitani M, Komiyama K, Arakawa Y (2000) Hepatitis G virus coinfection influences the liver histology of patients with chronic hepatitis C. Liver 20(5):397–404PubMedCrossRef

Title: Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus
Authors: M. García-Álvarez
J. Berenguer
E. Álvarez
M. Guzmán-Fulgencio
J. Cosín
P. Miralles
P. Catalán
J. C. López
J. Ma Rodríguez
D. Micheloud
Ma Á. Muñoz-Fernández
S. Resino
Publication date: 01-02-2013
Publisher: Springer-Verlag
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2013
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-012-1744-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2013

Paucisymptomatic infectious prostatitis as a cause of fever without an apparent origin. A series of 19 patients

Genetic structure of Aspergillus flavus populations in human and avian isolates

Unsolicited post-prescription antibiotic review in surgical and medical wards: factors associated with counselling and physicians’ compliance

Erratum to: Standard Nutrient Agar 1 as a substitute for blood-supplemented Müller–Hinton agar for antibiograms in developing countries

Standard Nutrient Agar 1 as a substitute for blood-supplemented Müller–Hinton agar for antibiograms in developing countries

Erratum to: Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials